Inflammatory bowel disease (IBD) has become a global disease with accelerating incidence
worldwide in the 21st century while its accurate etiology remains unclear. In the past …

Intestinal microbiome dysbiosis has been consistently described in patients with IBD. In the
last decades, Escherichia coli, and the adherent-invasive E coli (AIEC) pathotype in …

A growing body of documents shows microbiota produce metabolites such as short-chain
fatty acids (SCFAs) as crucial executors of diet-based microbial influence the host and …

Escherichia coli is one of the most-studied microorganisms worldwide but its characteristics
are continually changing. Extraintestinal E. coli infections, such as urinary tract infections …

Crohn's disease can affect any part of the gastrointestinal tract; however, current European
and national guidelines worldwide do not differentiate between small-intestinal and colonic …

Bladder infections affect millions of people yearly, and recurrent symptomatic infections
(cystitis) are very common. The rapid increase in infections caused by multidrug-resistant …

Intestinal inflammation arises from abnormal host–microbe interactions. The perturbations of
homeostatic coexistence involve host genetic factors, barrier function, innate and adaptive …

The ileal mucosa of Crohn disease (CD) patients is abnormally colonized by adherent-
invasive E. coli (AIEC) that are able to adhere to and invade intestinal epithelial cells. Here …

Abstract Escherichia coli (E. coli), and particularly the adherent invasive E. coli (AIEC)
pathotype, has been increasingly implicated in the ethiopathogenesis of Crohn's disease …

Inflammatory bowel disease (IBD) is a group of idiopathic, chronic and relapsing
inflammatory conditions of the gastrointestinal tract. Familial and epidemiological studies …